Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Synthon BV - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Synthon BV - Product Pipeline Review - 2014', provides an overview of the Synthon BV's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Synthon BV's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Synthon BV including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Synthon BV's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Synthon BV's pipeline products Reasons to buy - Evaluate Synthon BV's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Synthon BV in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Synthon BV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Synthon BV and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Synthon BV - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Synthon BV and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Synthon BV Snapshot 5 Synthon BV Overview 5 Key Information 5 Key Facts 5 Synthon BV - Research and Development Overview 6 Key Therapeutic Areas 6 Synthon BV - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 Synthon BV - Pipeline Products Glance 12 Synthon BV - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Synthon BV - Drug Profiles 14 Secretory IgA 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 SYD-985 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Biosimilar-2 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Immunotherapeutic IgG 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Monoclonal Antibody Conjugated 2 for Oncology 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Monoclonal Antibody Conjugated 3 for Oncology 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Monoclonal Antibody Conjugated 4 For Oncology 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Synthon BV - Pipeline Analysis 21 Synthon BV - Pipeline Products by Target 21 Synthon BV - Pipeline Products by Molecule Type 22 Synthon BV - Pipeline Products by Mechanism of Action 23 Synthon BV - Recent Pipeline Updates 24 Synthon BV - Dormant Projects 25 Synthon BV - Company Statement 26 Synthon BV - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 29 Disclaimer 29
List of Tables Synthon BV, Key Information 5 Synthon BV, Key Facts 5 Synthon BV - Pipeline by Indication, 2014 7 Synthon BV - Pipeline by Stage of Development, 2014 8 Synthon BV - Monotherapy Products in Pipeline, 2014 9 Synthon BV - Out-Licensed Products in Pipeline, 2014 10 Synthon BV - Out-Licensed Products/ Combination Treatment Modalities, 2014 11 Synthon BV - Preclinical, 2014 12 Synthon BV - Discovery, 2014 13 Synthon BV - Pipeline by Target, 2014 21 Synthon BV - Pipeline by Molecule Type, 2014 22 Synthon BV - Pipeline Products by Mechanism of Action, 2014 23 Synthon BV - Recent Pipeline Updates, 2014 24 Synthon BV - Dormant Developmental Projects,2014 25 Synthon BV, Subsidiaries 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.